Diagnostic Biotechnology (Pte.) Ltd. – Trademark Portfolio

Entity Type: 03

Diagnostic Biotechnology (Pte.) Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. The owner is based in Singapore Science Park.

65 Science Park Drive

Singapore Science Park 0511 , SG

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DB
DB
Cancelled 1990
DB
DB
Cancelled 1990

Trademark Classifications

Diagnostic Biotechnology (Pte.) Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Diagnostic Biotechnology (Pte.) Ltd. have?

Diagnostic Biotechnology (Pte.) Ltd. has 2 U.S. trademarks filed with the USPTO.

What trademark classes does Diagnostic Biotechnology (Pte.) Ltd. file in?

Diagnostic Biotechnology (Pte.) Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Diagnostic Biotechnology (Pte.) Ltd.'s trademark registration success rate?

Diagnostic Biotechnology (Pte.) Ltd. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.